Peter Richardson
Direttore Tecnico/Scientifico/R&S presso MALLINCKRODT PLC
Profilo
Peter C.
Richardson is currently the Chief Scientific Officer & Executive VP at Mallinckrodt Plc and a Member of The Royal College of Physicians.
Previously, he was the Chief Medical Officer & Executive VP-Research at Antares Pharma, Inc. from 2021 to 2022, the Chief Scientific Officer & Vice President at MannKind Corp.
from 2005 to 2012, the Senior VP & Global Head-Development Alliance at Novartis Pharmaceuticals Corp.
from 1991 to 2005, and the Senior Vice President & Head-Development at Novartis Pharma KK from 2003 to 2005.
He also served as the Chief Medical Officer at Adare Pharma Solutions, Inc. from 2016 to 2020.
Richardson received his undergraduate and doctorate degrees from The University of Nottingham.
Posizioni attive di Peter Richardson
| Società | Posizione | Inizio |
|---|---|---|
| MALLINCKRODT PLC | Direttore Tecnico/Scientifico/R&S | 12/01/2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Precedenti posizioni note di Peter Richardson
| Società | Posizione | Fine |
|---|---|---|
| ANTARES PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 24/05/2022 |
Adare Pharma Solutions, Inc.
 Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Presidente | 01/01/2016 |
| MANNKIND CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/10/2005 |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 01/01/2005 |
Formazione di Peter Richardson
| The University of Nottingham | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| Aziende private | 4 |
|---|---|
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Adare Pharma Solutions, Inc.
Adare Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Adare Pharma Solutions, Inc. provides pharmaceutical outsourcing services. Its technologies are used to develop novel prescription and OTC products. Its brands include Viactiv, and Lactéol. The company was founded in 1999 and is headquartered in Lawrenceville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Peter Richardson
